Literature DB >> 28189679

SOX10 induced Nestin expression regulates cancer stem cell properties of TNBC cells.

Wen Feng1, Sihai Liu2, Ruixia Zhu3, Baojian Li1, Zhu Zhu1, Jinshan Yang1, Chunhui Song1.   

Abstract

The mechanisms modulating the cancer stem cell (CSC) properties of triple negative breast cancer (TNBC) cells were not fully understood. In this study, we performed data mining in Breast Cancer Gene-Expression Miner v4.0 and found that TNBC tumors had significantly higher NES mRNA expression than other breast cancer subtypes. Pooled data suggested that NES mRNA expression is associated worse metastatic relapse (MR) free survival and also worse any event (AE) free survival in TNBC patients. Following data mining in multiple big data databases confirmed a positive correlation between SOX10 mRNA expression and NES mRNA expression in breast cancer tissues. In addition, the expression of SOX10 mRNA is significantly higher in TNBC tissues than in other breast cancer subtypes. SOX10 overexpression resulted in Nestin upregulation at both mRNA and protein levels. Bioinformatic analysis predicted a SOX10 binding site in NES promoter and the following dual luciferase assay verified the binding site. Functionally, SOX10 overexpression substantially increased CSC properties of TNBC cells, while SOX10 knockdown decreased the CSC properties, in terms of CD24-/CD44+ cell ratio and tumorsphere-forming capabilities. Enforced Nestin expression partly counteracted the effect of SOX10 knockdown on reducing the CSC properties. Based on these findings, we infer that SOX10 regulates cancer stem cell properties of TNBC cells via inducing Nestin expression.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer stem cell; Nestin; SOX10; TNBC

Mesh:

Substances:

Year:  2017        PMID: 28189679     DOI: 10.1016/j.bbrc.2017.02.014

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  Emerging Role of SOX Proteins in Breast Cancer Development and Maintenance.

Authors:  Gaurav A Mehta; Pooja Khanna; Michael L Gatza
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-05-09       Impact factor: 2.673

2.  Novel insights linking BRCA1-IRIS role in mammary gland development to formation of aggressive PABCs: the case for longer breastfeeding.

Authors:  Patricia Castillo; Omonigho Aisagbonhi; Cheryl C Saenz; Wael M ElShamy
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

3.  Identification and functional analysis of SOX10 phosphorylation sites in melanoma.

Authors:  Julia C Cronin; Stacie K Loftus; Laura L Baxter; Steve Swatkoski; Marjan Gucek; William J Pavan
Journal:  PLoS One       Date:  2018-01-09       Impact factor: 3.240

4.  Identification of Key Genes and Pathways in Triple-Negative Breast Cancer by Integrated Bioinformatics Analysis.

Authors:  Pengzhi Dong; Bing Yu; Lanlan Pan; Xiaoxuan Tian; Fangfang Liu
Journal:  Biomed Res Int       Date:  2018-08-02       Impact factor: 3.411

Review 5.  The Strange Case of Jekyll and Hyde: Parallels Between Neural Stem Cells and Glioblastoma-Initiating Cells.

Authors:  David Bakhshinyan; Neil Savage; Sabra Khalid Salim; Chitra Venugopal; Sheila K Singh
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

6.  SH3KBP1 Promotes Glioblastoma Tumorigenesis by Activating EGFR Signaling.

Authors:  Hai Song; Yanpei Wang; Chaojia Shi; Jianxiang Lu; Tian Yuan; Xiangpeng Wang
Journal:  Front Oncol       Date:  2021-02-11       Impact factor: 6.244

Review 7.  Sex-Determining Region Y Chromosome-Related High-Mobility-Group Box 10 in Cancer: A Potential Therapeutic Target.

Authors:  Liming Yu; Fan Peng; Xue Dong; Ying Chen; Dongdong Sun; Shuai Jiang; Chao Deng
Journal:  Front Cell Dev Biol       Date:  2020-12-03

8.  AKT-mediated phosphorylation of Sox9 induces Sox10 transcription in a murine model of HER2-positive breast cancer.

Authors:  Khalid N Al-Zahrani; John Abou-Hamad; Julia Pascoal; Cédrik Labrèche; Brennan Garland; Luc A Sabourin
Journal:  Breast Cancer Res       Date:  2021-05-13       Impact factor: 6.466

9.  LncRNA ENST869 Targeting Nestin Transcriptional Region to Affect the Pharmacological Effects of Chidamide in Breast Cancer Cells.

Authors:  Xiuyan Feng; Han Han; Yarui Guo; Xue Feng; Shanchun Guo; Weiqiang Zhou
Journal:  Front Oncol       Date:  2022-04-04       Impact factor: 5.738

10.  CircRNA EPHB4 modulates stem properties and proliferation of gliomas via sponging miR-637 and up-regulating SOX10.

Authors:  Chen Jin; Jie Zhao; Zhi-Ping Zhang; Ming Wu; Jian Li; Bo Liu; Xin- Bin Liao; Yu-Xiang Liao; Jing-Ping Liu
Journal:  Mol Oncol       Date:  2020-12-16       Impact factor: 7.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.